ES2170076T3 - Nuevos alcoholes 7-(ciclopentilo sustituido en 5) y (ciclopentenilo sustituido en 5)-heptilicos, heptilaminas y amidas de acido heptanoico, y metodo de disminuir la presion intraocular en el ojo de un mamifero por administracion de estos nuevos compuestos. - Google Patents

Nuevos alcoholes 7-(ciclopentilo sustituido en 5) y (ciclopentenilo sustituido en 5)-heptilicos, heptilaminas y amidas de acido heptanoico, y metodo de disminuir la presion intraocular en el ojo de un mamifero por administracion de estos nuevos compuestos.

Info

Publication number
ES2170076T3
ES2170076T3 ES93924387T ES93924387T ES2170076T3 ES 2170076 T3 ES2170076 T3 ES 2170076T3 ES 93924387 T ES93924387 T ES 93924387T ES 93924387 T ES93924387 T ES 93924387T ES 2170076 T3 ES2170076 T3 ES 2170076T3
Authority
ES
Spain
Prior art keywords
replaced
lower alkyl
eye
intraocular pressure
heptilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93924387T
Other languages
English (en)
Inventor
Michael E Garst
Robert Burk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ES2170076T3 publication Critical patent/ES2170076T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE LA FORMULA (1) EN LA QUE LA LINEA PUNTEADA REPRESENTA UN ENLACE O LA AUSENCIA DE UN ENLACE, LAS LINEAS ONDULADAS REPRESENTAN ENLACES QUE TIENEN CONFIGURACION CIS O TRANS; R1 REPRESENTA H, O CO-R2 EN DONDE R2 ES ALQUIL INFERIOR C1-C16, ARILO CARBOCICLICO O ARILO HEROCICLICO; O UN GRUPO DE ALQUILO INFERIOR SUBSTITUIDO CON ARILO CARBOCICLICO O HETEROARILO; X REPRESENTA CONR3R4, CH2OH,CH2OR5, CH2O-COR6 Y CH2-NR3R4, EN DONDE R3 Y R4 SON INDEPENDIENTEMENTE H O ALQUILO INFERIOR, R5 ES ALQUILO INFERIOR C1C6, Y R6 ES ALQUILO INFERIOR C1-C6, ARILO CARBOCICLICO O ARILO HETEROCICLICO; O UN GRUPO DE ALQUILO INFERIOR SUBSTITUIDO CON ARILO CARBOCICLICO O ARILO HETEROCICLICO, Y N ES UN ENTERO ENTRE 0 Y 8; LOS COMPUESTOS SON CAPACES DE HACER DESCENDER LA PRESION INTRAOCULAR EN EL OJO DE UN MAMIFERO.
ES93924387T 1992-10-21 1993-10-20 Nuevos alcoholes 7-(ciclopentilo sustituido en 5) y (ciclopentenilo sustituido en 5)-heptilicos, heptilaminas y amidas de acido heptanoico, y metodo de disminuir la presion intraocular en el ojo de un mamifero por administracion de estos nuevos compuestos. Expired - Lifetime ES2170076T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/964,223 US5385945A (en) 1992-10-21 1992-10-21 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds

Publications (1)

Publication Number Publication Date
ES2170076T3 true ES2170076T3 (es) 2002-08-01

Family

ID=25508274

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93924387T Expired - Lifetime ES2170076T3 (es) 1992-10-21 1993-10-20 Nuevos alcoholes 7-(ciclopentilo sustituido en 5) y (ciclopentenilo sustituido en 5)-heptilicos, heptilaminas y amidas de acido heptanoico, y metodo de disminuir la presion intraocular en el ojo de un mamifero por administracion de estos nuevos compuestos.

Country Status (9)

Country Link
US (4) US5385945A (es)
EP (1) EP0665751B1 (es)
JP (1) JPH08502495A (es)
AT (1) ATE211386T1 (es)
AU (1) AU669957B2 (es)
CA (1) CA2147502C (es)
DE (1) DE69331417T2 (es)
ES (1) ES2170076T3 (es)
WO (1) WO1994008587A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268387A (en) * 1992-04-24 1993-12-07 Allergan, Inc. Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss
US5385945A (en) * 1992-10-21 1995-01-31 Allergan, Inc. 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
WO1998021180A1 (en) 1995-06-07 1998-05-22 Alcon Laboratories, Inc. Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
US6441047B2 (en) 1995-11-17 2002-08-27 Alcon Manufacturing Ltd.. Combination therapy for treating glaucoma
WO2000039194A1 (fr) * 1998-12-25 2000-07-06 Mitsui Chemicals, Incorporated Procedes servant a preparer une resine absorbant l'eau
US6864282B2 (en) 2002-08-05 2005-03-08 Allergan, Inc. 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
US20040216749A1 (en) * 2003-01-23 2004-11-04 Hosheng Tu Vasomodulation during glaucoma surgery
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
WO2006041875A1 (en) 2004-10-06 2006-04-20 Allergan, Inc. Novel prostamides for the treatment of glaucoma and related diseases
PL2084124T3 (pl) * 2006-10-02 2014-08-29 Techfields Biochem Co Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki prostaglandyn i związków pokrewnych o bardzo dużych szybkościach przenikania przez skórę
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP5925158B2 (ja) * 2013-06-04 2016-05-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6030168B2 (ja) * 2015-03-09 2016-11-24 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6306067B2 (ja) * 2016-01-08 2018-04-04 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935261A (en) * 1970-01-23 1976-01-27 May & Baker Limited Cyclopentane derivatives
US4054604A (en) * 1974-01-10 1977-10-18 American Cyanamid Company Amide derivatives of 9-oxo-13-trans-prostenoic acid
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
DE2629834A1 (de) * 1976-06-30 1978-01-12 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
US4058564A (en) * 1976-07-26 1977-11-15 The Upjohn Company Aliphatic 2-decarboxy-2-hydroxymethyl-13,14-didehydro-PG compounds
DE2715838A1 (de) * 1977-04-05 1978-10-19 Schering Ag Neue prostanderivate und verfahren zu ihrer herstellung
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0242580B1 (en) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Use of a, b and c prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
IT1205183B (it) * 1987-06-25 1989-03-15 Istituto Biochimico Italiano Derivati prostaglandinici,procedimenti per prepararli e composizioni farmaceutiche che li contengono
WO1990002553A1 (en) * 1988-09-06 1990-03-22 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0425584A1 (en) * 1988-09-20 1991-05-08 IBI- Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. Prostaglandin-derivatives having antithrombotic activity
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
KR0178542B1 (ko) * 1991-01-30 1999-05-15 모찌즈끼 노부히꼬 디티오카르밤산의 염류, 그 제조방법 및 그 디티오카르밤산의 염류를 사용하는 이소티오시아네이트류의 제조방법
IE920397A1 (en) * 1991-02-07 1992-08-12 Allergan Inc 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f¹derivatives
US5385945A (en) * 1992-10-21 1995-01-31 Allergan, Inc. 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds

Also Published As

Publication number Publication date
ATE211386T1 (de) 2002-01-15
JPH08502495A (ja) 1996-03-19
US5385945A (en) 1995-01-31
DE69331417D1 (de) 2002-02-07
US5773654A (en) 1998-06-30
AU5409494A (en) 1994-05-09
CA2147502A1 (en) 1994-04-28
WO1994008587A1 (en) 1994-04-28
DE69331417T2 (de) 2002-08-29
EP0665751A1 (en) 1995-08-09
US5552434A (en) 1996-09-03
US5674910A (en) 1997-10-07
EP0665751B1 (en) 2002-01-02
CA2147502C (en) 2005-05-17
AU669957B2 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
ES2170076T3 (es) Nuevos alcoholes 7-(ciclopentilo sustituido en 5) y (ciclopentenilo sustituido en 5)-heptilicos, heptilaminas y amidas de acido heptanoico, y metodo de disminuir la presion intraocular en el ojo de un mamifero por administracion de estos nuevos compuestos.
ES8404993A1 (es) Procedimiento para preparar derivados de piridina
ZA911153B (en) Process for the preparation of oxetanones
CA1262357A (en) N-HYDROXYL PROTECTIVE GROUPS AND METHOD FOR THE PREPARATION OF 3-ACYLAMINO-1-HYDROXY-2-AZETIDINONES
FI823923A0 (fi) Antifibrinolytiskt aktiva foereningar
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
ES8100273A1 (es) Procedimiento para la preparacion de nuevos derivados de alfa-(3,4-diclorofenil)-2-imidazolina-2-metanol y alfa-(3,4-diclorofenil)-1,4,5,6-tetrahidro-2-pirimidinametanol
NZ506853A (en) C11 oxymyl and hydroxylamino prostaglandins (PGF) analogs useful as medicaments
AU550340B2 (en) Dibenzazepine derivatives
NZ506855A (en) C11 Oxymyl and hydroxylamino prostaglandins useful as FP agonists
ES2002663A6 (es) Procedimiento para la preparacion de diazaoxaespirodecanos sustituidos como estabilizadores para polimeros
ES8707508A1 (es) Procedimiento para preparar derivados del estilbeno asimetricos conteniendo triazinilo
NO883080L (no) Fremgangsmaate for fremstilling av nye cefemforbindelser.
ES8201959A1 (es) Procedimiento para preparar 3,3'-azo-bis-(acido 6-hidroxi- benzoico)
FI892681A0 (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
DE3264928D1 (en) Process for producing brominated 1,3-dioxolen-2-ones
MA19841A1 (fr) Procede de preparation de nouveaux derives de cephalosporines utilisables comme antibiotiques .
TW230190B (es)
ATE29496T1 (de) Tetrahydro-beta-carbolin-derivate und verfahren fuer ihre herstellung.
ES8603502A1 (es) Procedimiento para la obtencion de trans,trans-8,10-dodeca- dien-1-iloxisilanos
UA19274A (uk) Засіб для підвищеhhя продуктивhості шовковичhого шовкопряда
JPS6426559A (en) Novel phthalide derivative
SE8207474L (sv) Nya heterocykliska karboxylsyror och ett forfarande for framstellning derav
ATE18042T1 (de) Semicarbazide, ihre herstellung und verwendung.
FI952243L (fi) Tetratsolijohdannaisia

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 665751

Country of ref document: ES